Compare Cassava Sciences Inc (FLNA) vs Shopify Inc. (SHOP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Shopify Inc. — how do they compare? Cassava Sciences Inc trades at $1.08 (market cap $53.14M), while Shopify Inc. trades at $126.87 (market cap $160.33B). The key difference: Shopify Inc. is far larger — about 3017.1× Cassava Sciences Inc's market cap, and Shopify Inc. is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | SHOP | |
|---|---|---|
Market Cap | $53.14M | $160.33B |
Sector | Health | Technology |
52-Week High | $4.64 | $179.01 |
52-Week Low | $1.09 | $95.40 |
Enterprise Value | -$33.43M | $154.76B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
Shopify (SHOP) trades at $125.86, up 0.14% on the day, with a bullish technical signal from moving averages and support at $121. The company reported $11.56B revenue in 2025 with a 10.77% net margin, though valuation ratios remain elevated with a P/E of 121. Recent analyst upgrades highlight AI commerce growth potential.
Outlook is positive with a $150.08 consensus price target and 67% buy ratings, but high valuation and competitive pressures pose risks. Earnings beat in Q1 2026 supports momentum, yet investors should weigh growth against premium multiples in a volatile market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Shopify Inc.
Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →
